Breaking News Instant updates and real-time market news.

2020-11-24 09:39:05 ALT Altimmune $9.23 / -0.07 (-0.75%) , AZN AstraZeneca $54.70 / -0.59 (-1.07%) 09:39 11/24/20 11/24 09:39 11/24/20 09:39	Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler Piper Sandler analyst Yasmeen Rahimi says the positive Covid-19 vaccine results reported yesterday by AstraZeneca's (AZN) AZD1222, an adenovirus-based candidate, are "de-risking" for adeno-based vaccine candidates, notably Altimmune's (ALT) AdCOVID. "Strong efficacy and clean safety" signal that adenovirus-based vaccines can compete with the results from the two mRNA vaccines, Rahimi tells investors in a research note. The analyst believes Altimmune's AdCOVID can have a higher efficacy "ceiling" than AZD1222. Rahimi keeps an Overweight rating on Altimmune with an $80 price target. ALT Altimmune $9.23 / -0.07 (-0.75%) AZN AstraZeneca $54.70 / -0.59 (-1.07%)	30 Nov 05 Dec 08 Dec 09 Dec 14 Jul
ALT AZN ALT Altimmune $9.23 / -0.07 (-0.75%) 11/12/20 B. Riley Securities Altimmune selloff on vaccine news overblown, says B. Riley Securities 10/12/20 Piper Sandler Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program 09/25/20 B. Riley Securities Altimmune initiated with a Buy at B. Riley FBR 09/22/20 Piper Sandler Altimmune nearing two 'key stock-moving events,' says Piper Sandler AZN AstraZeneca $54.70 / -0.59 (-1.07%) 11/23/20 Morgan Stanley AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley 11/23/20 SVB Leerink AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink 11/11/20 Oppenheimer Amgen price target raised to $280 from $275 at Oppenheimer 11/11/20 HSBC AstraZeneca upgraded to Hold from Reduce at HSBC

2020-11-24 09:39:05

ALT

Altimmune

$9.23 / -0.07 (-0.75%)

, AZN

AstraZeneca

$54.70 / -0.59 (-1.07%)

09:39

11/24/20

11/24

09:39

11/24/20

09:39

Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler

Piper Sandler analyst Yasmeen Rahimi says the positive Covid-19 vaccine results reported yesterday by AstraZeneca's (AZN) AZD1222, an adenovirus-based candidate, are "de-risking" for adeno-based vaccine candidates, notably Altimmune's (ALT) AdCOVID. "Strong efficacy and clean safety" signal that adenovirus-based vaccines can compete with the results from the two mRNA vaccines, Rahimi tells investors in a research note. The analyst believes Altimmune's AdCOVID can have a higher efficacy "ceiling" than AZD1222. Rahimi keeps an Overweight rating on Altimmune with an $80 price target.

ALT

Altimmune

$9.23 / -0.07 (-0.75%)

AZN

AstraZeneca

$54.70 / -0.59 (-1.07%)

30
Nov
05
Dec
08
Dec
09
Dec

14
Jul

ALT Altimmune

$9.23 / -0.07 (-0.75%)

11/12/20 B. Riley Securities: Altimmune selloff on vaccine news overblown, says B. Riley Securities

10/12/20 Piper Sandler: Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program

09/25/20 B. Riley Securities: Altimmune initiated with a Buy at B. Riley FBR

09/22/20 Piper Sandler: Altimmune nearing two 'key stock-moving events,' says Piper Sandler

AZN AstraZeneca

$54.70 / -0.59 (-1.07%)

11/23/20 Morgan Stanley: AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley

11/23/20 SVB Leerink: AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink

11/11/20 Oppenheimer: Amgen price target raised to $280 from $275 at Oppenheimer

11/11/20 HSBC: AstraZeneca upgraded to Hold from Reduce at HSBC

TODAY'S FREE FLY STORIES

Recommendations	Vermilion Energy price target raised to C$8 from C$7 at RBC Capital » 11:11 01/20/21 01/20 11:11 01/20/21 11:11 VET Vermilion Energy $5.80 / +0.28 (+5.07%) RBC Capital analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/17/20 Vermilion Energy announces changes to its leadership team 09/24/20 Vermilion Energy provides update on Total's Grandpuits refinery conversion VET Vermilion Energy $5.80 / +0.28 (+5.07%) 01/19/21 National Bank Vermilion Energy price target lowered to C$6.50 from C$7 at National Bank 01/19/21 TD Securities Vermilion Energy price target lowered to C$6.50 from C$7 at TD Securities 01/15/21 Raymond James Vermilion Energy upgraded to Outperform from Market Perform at Raymond James 01/14/21 Scotiabank Vermilion Energy price target raised to C$8.50 from C$8 at Scotiabank VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/09/20 Vermilion Energy reports Q3 FFO 73c vs. $1.39 last year 07/27/20 Vermilion Energy reports Q2 FFO 52c vs. $1.09 last year
Options	Bull tries on $2M worth of Under Armour March 20 calls » 11:10 01/20/21 01/20 11:10 01/20/21 11:10 UAA Under Armour $18.45 / +0.325 (+1.79%) Bull tries on $2M worth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options UAA Under Armour $18.45 / +0.325 (+1.79%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal UAA Under Armour $18.45 / +0.325 (+1.79%) 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities 01/07/21 JPMorgan Under Armour price target raised to $19 from $17 at JPMorgan 01/04/21 Pivotal Research Under Armour upgraded to Buy from Hold at Pivotal Research 12/09/20 UBS Under Armour price target raised to $17 from $10 at UBS UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open UAA Under Armour $18.45 / +0.325 (+1.79%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 07/31/20 Fly Intel: Pre-market Movers 07/27/20 Fly Intel: Pre-market Movers UAA Under Armour $18.45 / +0.325 (+1.79%) 12/08/20 Unusual call flow in option market yesterday 12/07/20 Upside call buyer in Under Armour closing position 12/07/20 Unusually active option classes on open December 7th 10/30/20 Unusually active option classes on open October 30th
Recommendations	Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital » 11:09 01/20/21 01/20 11:09 01/20/21 11:09 CSFFF Capstone Mining $0.00 / + (+0.00%) BMO Capital analyst Rene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 11:00 Today TD Securities Capstone Mining price target raised to C$3.50 from C$3 at TD Securities 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank
On The Fly	Netflix subscriber growth, buyback potential wins over two new bulls » 11:07 01/20/21 01/20 11:07 01/20/21 11:07 NFLX Netflix $571.28 / +69.24 (+13.79%) Shares of Netflix (NFLX)… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $571.28 / +69.24 (+13.79%) 09:56 Today Fly Intel: Top five analyst upgrades 09:18 Today JPMorgan Netflix price target raised to $685 from $628 at JPMorgan 09:04 Today Morgan Stanley Netflix price target raised to $700 from $650 at Morgan Stanley 09:00 Today Wedbush Netflix price target raised to $340 from $235 at Wedbush NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $571.28 / +69.24 (+13.79%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $571.28 / +69.24 (+13.79%) 08:59 Today Fly Intel: Pre-market Movers 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 12/09/20 Disney rises as Wall Street analysts get more bullish ahead of investor day NFLX Netflix $571.28 / +69.24 (+13.79%) 09:55 Today Early notable gainers among liquid option names on January 20th 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th
Recommendations	Theratechnologies price target lowered to C$3.75 from C$4 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 THTX Theratechnologies $2.26 / -0.005 (-0.22%) National Bank lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies gets Study May Proceed letters for tesamorelin, TH1902 trials 12/08/20 Theratechnologies announces preclinical in vivo findings for TH1902 11/16/20 Theratechnologies announces data from oral presentation at AASLD 11/03/20 Theratechnologies announces departure of Chief Commercial Officer Antunovic THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies sees 2020 revenue $65.8M-$66.1M vs. $63.2M last year 01/07/21 Theratechnologies sees Q4 revenue $18.9M-$19.2M vs. $16.4M last year 10/15/20 Theratechnologies reports Q3 EPS (9c) vs. (2c) last year 09/21/20 Theratechnologies sees Q3 revenue $13.8M-$14.2M vs. 16.1M last year

Recommendations	CanWel Building price target raised to C$8.50 from C$7.50 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 CWXZF CanWel Building Materials $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CWXZF CanWel Building Materials $0.00 / + (+0.00%) 01/04/21 Raymond James CanWel Building Materials price target raised to C$9 at Raymond James 12/18/20 CIBC CanWel Building Materials price target raised to C$8.25 from C$8 at CIBC 12/16/20 National Bank CanWel price target lowered to C$7.50 from C$8 at National Bank 11/10/20 CIBC CanWel Building Materials price target raised to C$8 from C$7 at CIBC
Upgrade	Healthpeak upgraded to Overweight from Equalweight at Capital One » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 PEAK Healthpeak $29.67 / +0.52 (+1.78%) Capital One analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events PEAK Healthpeak $29.67 / +0.52 (+1.78%) 01/05/21 Baird Healthpeak assumed with an Outperform at Baird 12/29/20 Barclays Healthpeak price target raised to $33 from $30 at Barclays 12/15/20 Citi Healthpeak price target raised to $30 from $28 at Citi 12/14/20 KeyBanc Healthpeak downgraded to Sector Weight from Overweight at KeyBanc PEAK Healthpeak $29.67 / +0.52 (+1.78%) 11/02/20 Healthpeak reports Q3 AFFO 40c, consensus 39c 08/04/20 Healthpeak reports Q2 AFFO 40c, consensus 40c 02/10/21 Healthpeak - PEAK
Options	First Majestic Silver call volume above normal and directionally bullish » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 AG First Majestic $13.36 / +0.7 (+5.53%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AG First Majestic $13.36 / +0.7 (+5.53%) 07:23 Today First Majestic plans to invest $168.4M on capital expenditures in 2021 07:22 Today First Majestic budgets $42.1M to be invested at Ermitano in 2021 07:20 Today First Majestic sees 2021 total production 20.6M-22.9M silver equivalent ounces 07:18 Today First Majestic reports 2020 silver production of 11.6M ounces AG First Majestic $13.36 / +0.7 (+5.53%) 01/11/21 National Bank First Majestic price target raised to C$20 from C$18 at National Bank 10/22/20 National Bank First Majestic price target lowered to C$18 from C$20 at National Bank 10/20/20 TD Securities First Majestic upgraded to Buy from Hold at TD Securities 09/11/20 National Bank First Majestic price target raised to C$20 from C$19 at National Bank AG First Majestic $13.36 / +0.7 (+5.53%) 11/05/20 First Majestic reports Q3 adj. EPS 12c, two est. (2c) 03/15/21 33rd Annual Roth Virtual Conference 10:00 Today First Majestic - AG AG First Majestic $13.36 / +0.7 (+5.53%) 01/19/21 First Majestic Silver call volume above normal and directionally bullish 12/21/20 First Majestic Silver call volume above normal and directionally bullish 12/16/20 First Majestic Silver call volume above normal and directionally bullish 12/15/20 First Majestic Silver call volume above normal and directionally bullish
Recommendations	Pan American Silver price target lowered to C$56 from C$60 at National Bank » 11:04 01/20/21 01/20 11:04 01/20/21 11:04 PAAS Pan American Silver $31.01 / +1.49 (+5.05%) National Bank analyst Don… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 01/19/21 Pan American Silver sees FY21 silver production up 35% from last year 11/04/20 Pan American Silver reports Q3 EPS 31c, consensus 38c 09/30/20 Pan American Silver restarts Huaron, Morococha operations in Peru 08/05/20 Pan American Silver reports mineral reserves estimate of 550M ounces of silver PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 07:43 Today Deutsche Bank Pan American Silver price target lowered to $26 from $35 at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/11/21 National Bank Pan American Silver price target raised to C$60 from C$57 at National Bank PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 11/04/20 Pan American Silver reports Q3 adj. EPS 34c, consensus 38c 08/05/20 Pan American Silver reports Q2 adjusted EPS 28c, consensus 6c 02/18/21 Pan American Silver - PAAS PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 12/11/20 Pan American Silver put volume heavy and directionally bearish 10/08/20 Pan American Silver put volume heavy and directionally bearish 08/11/20 Unusually active option classes on open August 11th 08/05/20 Pan American Silver call volume above normal and directionally bullish
Recommendations	Fortuna Silver Mines price target lowered to C$13 from C$14 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/19/21 Fortuna Silver Mines sees FY21 gold production 178,000-202,000 ounces 01/19/21 Fortuna Silver Mines reports FY20 silver production of 7.13M ounces, up 19% 12/01/20 Fortuna Silver Mines provides update on disputed royalty at San Jose Mine 10/20/20 Fortuna Silver Mines announces first gold pour at Lindero mine FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/11/21 National Bank Fortuna Silver Mines price target raised to C$14 from C$11 at National Bank 11/16/20 Canaccord Fortuna Silver Mines downgraded to Hold from Buy at Canaccord 09/16/20 CIBC Fortuna Silver Mines price target raised to C$11.50 from C$10 at CIBC 09/11/20 National Bank Fortuna Silver Mines price target raised to C$11 from C$10.50 at National Bank FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c 08/13/20 Fortuna Silver Mines reports Q2 EPS (3c), consensus 11c FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/08/21 Fortuna Silver Mines call volume above normal and directionally bullish 10/14/20 Largest borrow rate increases among liquid names 09/04/20 Fortuna Silver Mines call volume above normal and directionally bullish 07/20/20 Fortuna Silver Mines call volume above normal and directionally bullish

Recommendations	Exchange Income price target raised to C$42 from C$40 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 EIFZF Exchange Income $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $0.00 / + (+0.00%) 11/17/20 Scotiabank Exchange Income price target raised to C$38 from C$32 at Scotiabank 11/16/20 Canaccord Exchange Income price target raised to C$41 from C$36 at Canaccord 11/16/20 RBC Capital Exchange Income price target raised to C$40 from C$36 at RBC Capital 11/16/20 National Bank Exchange Income price target raised to C$40 from C$36 at National Bank
Recommendations	Whitecap Resources price target raised to C$6 from C$2.50 at Scotiabank » 11:01 01/20/21 01/20 11:01 01/20/21 11:01 SPGYF Whitecap Resources $0.00 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SPGYF Whitecap Resources $0.00 / + (+0.00%) 01/15/21 RBC Capital Whitecap Resources price target raised to C$6.50 from C$3.50 at RBC Capital 12/16/20 CIBC Whitecap Resources price target raised to C$7 from C$6 at CIBC 12/11/20 TD Securities Whitecap Resources price target raised to C$5.50 from C$3.25 at TD Securities 12/11/20 TD Securities TORC Oil and Gas downgraded to Tender from Buy at TD Securities
Recommendations	Capstone Mining price target raised to C$3.50 from C$3 at TD Securities » 11:00 01/20/21 01/20 11:00 01/20/21 11:00 CSFFF Capstone Mining $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank 12/17/20 BMO Capital Capstone Mining upgraded to Outperform from Market Perform at BMO Capital
Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:57 01/20/21 01/20 10:57 01/20/21 10:57 DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies 11:00 Today Danimer Scientific - DNMR DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/07/21 Three new option listings and one option delisting on January 7th
General news	Treasury Action: Treasuries are holding modest losses » 10:55 01/20/21 01/20 10:55 01/20/21 10:55 Treasury Action:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial

Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:52 01/20/21 01/20 10:52 01/20/21 10:52 DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/07/21 Three new option listings and one option delisting on January 7th
Recommendations	iClick Interactive Asia price target raised to $18 from $12 at Alliance Global » 10:51 01/20/21 01/20 10:51 01/20/21 10:51 ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) Alliance Global Partners… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 12/10/20 iClick Interactive Asia authorizes $15M share repurchase program 11/24/20 iClick Interactive Asia sees FY20 revenue $240M-$260M 11/12/20 iClick Interactive Asia to be added to MSCI China Small Cap Index 11/11/20 iClick Interactive Asia to acquire CMRS Group, terms not disclosed ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 09/29/20 China Renaissance iClick Interactive Asia initiated with a Buy at China Renaissance 09/10/20 Alliance Global Partners iClick Interactive Asia price target raised to $12 from $10 at Alliance Global Partners 08/24/20 Roth Capital iClick Interactive Asia price target raised to $11.50 from $7.50 06/22/20 Alliance Global Partners iClick Interactive Asia price target raised to $10 from $8 at Alliance Global ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 11/24/20 iClick Interactive Asia sees Q4 revenue $73M-$76M, consensus $74.41M 11/24/20 iClick Interactive Asia reports Q3 adjusted EPS 3c, consensus 1c 08/24/20 iClick Interactive Asia sees FY20 revenue $240M-$260M, consensus $249.16M 08/24/20 iClick Interactive Asia sees Q3 revenue $66M-$70M, consensus $68.34M 03 Sep ICLK iClick Interactive Asia $13.12 / -0.59 (-4.30%) 08/24/20 Fly Intel: Pre-market Movers
Syndicate	Legato Merger Corp. opens at $10.15, IPO priced at $10 per unit » 10:50 01/20/21 01/20 10:50 01/20/21 10:50 LEGO Legato Merger Corp. $0.00 / + (+0.00%) Legato Merger Corp.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Tenax Therapeutics to host conference call » 10:46 01/20/21 01/20 10:46 01/20/21 10:46 TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) 01/19/21 Tenax Therapeutics announces 'transformative' acquisition of PH Precision Med TENX Tenax Therapeutics $2.30 / -0.08 (-3.36%) 12/29/20 H.C. Wainwright Tenax Therapeutics initiated with a Buy at H.C. Wainwright
Options	iQiyi call volume above normal and directionally bullish » 10:45 01/20/21 01/20 10:45 01/20/21 10:45 IQ iQIYI $20.29 / +0.805 (+4.13%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options IQ iQIYI $20.29 / +0.805 (+4.13%) 01/14/21 iQIYI announces 'Deer Squad' to premiere in the U.S. this month 01/07/21 iQIYI North America appoints Justin Poy Agency as media sales partner 12/31/20 iQIYI receives ISO/IEC 27701 certification 11/16/20 iQIYI falls 5% to $26.50 after Q3 results, Q4 guidance IQ iQIYI $20.29 / +0.805 (+4.13%) 01/19/21 UBS iQIYI downgraded to Neutral from Buy at UBS 01/13/21 HSBC iQIYI downgraded to Hold with 'structural risks mounting' at HSBC 01/13/21 HSBC iQIYI downgraded to Hold from Buy at HSBC 01/12/21 Morgan Stanley iQIYI downgraded to Underweight from Equal Weight at Morgan Stanley IQ iQIYI $20.29 / +0.805 (+4.13%) 11/16/20 iQIYI sees Q4 revenue $1.07B-$1.14B, consensus $1.13B 11/16/20 iQIYI reports Q3 EPS (24c), consensus (40c) 08/13/20 iQIYI sees Q3 revenue $984.1M-$1.0B, consensus $1.07B 08/13/20 iQIYI reports Q2 EPS (28c), consensus (49c) 17 Dec IQ iQIYI $20.29 / +0.805 (+4.13%) 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports 10/13/20 Chinese online video platforms drop Apple iPhone event, Bloomberg's Yuan reports 10/13/20 Chinese platforms cancel Apple product unveiling livestream, Bloomberg says IQ iQIYI $20.29 / +0.805 (+4.13%) 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers 08/18/20 Fly Intel: Pre-market Movers IQ iQIYI $20.29 / +0.805 (+4.13%) 01/08/21 iQiyi call volume above normal and directionally bullish 12/24/20 Unusually active option classes on open December 24th 12/23/20 Unusually active option classes on open December 23rd 12/02/20 iQiyi call volume above normal and directionally bullish

Hot Stocks	Fastenal reports December sales up 14.7% to $428.84M » 10:43 01/20/21 01/20 10:43 01/20/21 10:43 FAST Fastenal $48.58 / -1.84 (-3.65%) Fastenal earlier, in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FAST Fastenal $48.58 / -1.84 (-3.65%) 06:52 Today Fastenal signed 3,456 industrial vending devices during Q4 01/19/21 Fastenal raises quarterly dividend to 28c from 25c per share 11/20/20 Fastenal announces special one-time dividend of 40c per share 09/04/20 Fastenal reports August sales down 2.2% to $465.22M FAST Fastenal $48.58 / -1.84 (-3.65%) 12/31/20 William Blair Azek, Trex among Blair's top Specialty Distribution ideas for 2021 12/16/20 Deutsche Bank Fastenal downgraded to Hold from Buy at Deutsche Bank 10/15/20 Stephens Fastenal resumed with an Overweight at Stephens 10/15/20 Argus Fastenal price target raised to $52 from $43 at Argus FAST Fastenal $48.58 / -1.84 (-3.65%) 06:50 Today Fastenal reports Q4 EPS 34c, consensus 33c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/13/20 Fastenal reports Q3 EPS 38c, consensus 37c FAST Fastenal $48.58 / -1.84 (-3.65%) 10/13/20 Fly Intel: Pre-market Movers 10:00 Today Fastenal - FAST
Hot Stocks	AIM ImmunoTech tweets about being featured by WFTV on COVID-19 efforts » 10:40 01/20/21 01/20 10:40 01/20/21 10:40 AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) The official Twitter of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 01/06/21 AIM ImmunoTech doses first COVID-19 chronic fatigue patient with Ampligen 12/24/20 AIM ImmunoTech announces IRB approval to enroll 'long haulers' in ampligen trial 12/24/20 AIM ImmunoTech announces AMP-511 EAP receives IRB approval for enrollment 12/21/20 AIM ImmunoTech: FDA grants Orphan Drug Designation status to Ampligen AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 04/06/20 Maxim AIM ImmunoTech price target raised to $5 from $2 at Maxim AIM AIM ImmunoTech $2.17 / +0.075 (+3.58%) 11/13/20 AIM ImmunoTech reports Q3 EPS (8c), consensus (8c) 08/17/20 AIM ImmunoTech reports Q2 EPS (11c), consensus (10c)
Hot Stocks	Fulton Financial considering new 2021 repurchase program » 10:34 01/20/21 01/20 10:34 01/20/21 10:34 FULT Fulton Financial $38.00 / +14 (+1.00%) Comments taken from Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FULT Fulton Financial $38.00 / +14 (+1.00%) 07:02 Today Fulton Financial sees 2021 net interest income $620M-$640M 11/25/20 Fulton Financial declares special cash dividend 11/23/20 Fulton Financial acquires all outstanding stock of BenefitWorks 10/21/20 Fulton Financial: Previous 2020 guidance withdrawn due to impact from COVID-19 FULT Fulton Financial $38.00 / +14 (+1.00%) 06/17/20 Raymond James Fulton Financial upgraded to Outperform from Market Perform at Raymond James 06/01/20 Stephens Fulton Financial initiated with an Equal Weight at Stephens FULT Fulton Financial $38.00 / +14 (+1.00%) 01/19/21 Fulton Financial reports Q4 EPS 30c, consensus 31c 10/20/20 Fulton Financial reports Q3 EPS 38c, consensus 20c 07/21/20 Fulton Financial reports Q2 EPS 24c, consensus 10c FULT Fulton Financial $38.00 / +14 (+1.00%) 01/19/21 Fly Intel: After-Hours Movers 10:00 Today Fulton Financial - FULT
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Teladoc call volume above normal and directionally bullish » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 TDOC Teladoc $248.27 / +15.53 (+6.67%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/14/21 Teladoc falls -3.7% 01/14/21 Teladoc down 2% pre-market as UnitedHealth debuts virtual primary care offering 01/14/21 Teladoc issues inaugural corporate social responsibility report 01/11/21 Teladoc, DexCom announce CGM-powered insights for diabetes patients TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/19/21 JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/15/21 Benchmark SOC Telemed initiated with a Buy at Benchmark 01/12/21 BTIG Teladoc price target raised to $260 from $240 at BTIG 01/12/21 Piper Sandler Teladoc visibility improving, fundamentals attractive, says Piper Sandler TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/28/20 Teladoc sees FY20 EPS $(1.36)-($1.32)., consensus ($1.40) 10/28/20 Teladoc sees Q4 EPS (36c)-(33c), consensus (35c) 10/28/20 Teladoc reports Q3 EPS (43c), consensus (32c) 10/28/20 Notable companies reporting after market close TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/21/20 Teladoc accuses Amwell of patent infringement, STAT reports TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/16/20 Teladoc slides on report of Amazon building telehealth business 10/28/20 Fly Intel: After-Hours Movers 08/05/20 Fly Intel: Pre-market Movers TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/22/20 Teladoc call volume above normal and directionally bullish 12/22/20 Unusually active option classes on open December 22nd 12/21/20 Unusually active option classes on open December 21st 09/01/20 Teladoc call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler

TODAY'S FREE FLY STORIES

Get Full Fly Access